George Kirk is a Director of Global Products in the Oncology Global Medicines Development function at AstraZeneca and is responsible for the cross-functional project management, development and delivery of new Oncology products to market. George has been at AstraZeneca for 19 years and has spent the last 8-9 years in project management roles including 2 years as a Lean Sigma Black Belt in the Continuous Improvement group. Prior to project management George spent the previous 10 years in Pharmaceutical Development as a Team Manager. During his time in these roles he has worked on a variety of Oncology, Infection and Respiratory and Inflammation projects in both Early and Late Phase Development. George’s training is in Synthetic Organic Chemistry, he completed his Ph.D by research in Synthetic Organic Chemistry at the University of Strathclyde, Glasgow in 1995.